Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Valeant
Valeant
Page 3 of 12
Health
T. Rowe Price Sues Valeant Over Alleged Fraud
By
Contributing Writer
August 18, 2016
Finance
Here’s Why Shares of Valeant are Soaring
By
Contributing Writer
August 17, 2016
Finance
How Valeant Defies the Warren Buffett School of Investing
By
Senior Editor
August 11, 2016
Finance
Valeant Executives May Be Facing Criminal Prosecution
By
Market Analyst
August 11, 2016
Finance
Bill Ackman Met Big Investors About Valeant at a Private Brainstorming Dinner
By
Digital Assets Editor
August 10, 2016
Finance
Valeant’s Troubles Aren’t Driving It To Lower Drug Prices
By
Crypto Correspondent
August 9, 2016
Health
Valeant’s CEO Says He Is Not Actively Shopping Core Assets
By
Senior Editor
August 9, 2016
Health
Here’s Why Shares of Valeant Are Jumping
By
Financial Writer
August 9, 2016
Finance
Widely Loathed Valeant Pharmaceuticals Gets New Top Lawyer and PR Exec
By
Editorial Team
August 8, 2016
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By
Crypto Correspondent
August 1, 2016
Health
The FDA Sees a Problem with Valeant’s New Glaucoma Eye Drops
By
Contributing Writer
July 22, 2016
Finance
Investors Pull $600M After Ackman’s Bad Bets
By
Research Team
July 19, 2016
Finance
Former Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company
By
Blockchain Reporter
July 13, 2016
Finance
Valeant’s Second Largest Investor Just Dumped the Rest of Its Stock
By
Tech Reporter
July 13, 2016
Health
New Valeant CEO Meets Investors Amid Company Struggles
By
Tech Reporter
June 14, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Trading Desk
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Industry Analyst
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Crypto Correspondent